Clinical Trials, Phase III as Topic: Clinical Trials

14 trials of Clinical Trials, Phase III as Topic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 active not recruiting, 2 terminated, 1 unknown. 5 Phase 3, 4 Not applicable, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Terminated 2, Unknown 1
Not applicable4Active not recruiting 2, Completed 2
Phase 23Terminated 2, Unknown 1

Follow Clinical Trials, Phase III as Topic: new trials by email Literature Review of Clinical Trials, Phase III as Topic trials Research Report on Clinical Trials, Phase III as Topic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Blood Flow Restriction Training in Cardiac Patients: CARDresfluj Study
Blood Flow Restriction Exercise, Traditional Cardiac Rehabilitation, phase III - Cardiac Rehabilitation
Not applicableActive not recruitingUniversity of Valencia202026-02-012026-04-27
Oral Proprioceptive Sensitivity and Upper Limb Kinesthetic Acuity: A Pilot Study
Upper-Limb Kinesthetic Acuity Assessment, Effect of Auditory Stimulation on Visual Perception, Oral Proprioceptive Sensitivity Assessment - Oral Proprioceptive Sensitivity and Upper Limb Kinesthetic Acuity
CompletedSophie Román Richon332024-01-142026-10-02
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
Outreach/navigator, Auxiliary to care, Stepped care and task shifting - Depression, Unipolar, Anxiety Disorders
Not applicableActive not recruitingDrexel University6032023-11-102026-04-15
Study of the Effect of Proprioceptive Stimuli in the Stomatognathic Area on Visual Perception, With and Without Sound
Baseline Condition (No Stimuli), Auditory Stimulation only, Auditory and Oral Proprioceptive Stimulation (OPS) - Proprioception, Visual Perception
CompletedSophie Román Richon382022-12-162025-07-04
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident
Phase 2 / Phase 3TerminatedSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC322021-11-022026-05-27
Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11
Attenuated Mumps vaccine (KMB-17) in phase II and III, Placebo in phase II, Attenuated Mumps vaccine (KMB-17) in phase III - Epidemic Parotitis, Mumps
Phase 2 / Phase 3UnknownInstitute of Medical Biology, Chinese Academy of Medical Sciences119992020-10-122023-10-11
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity
Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity
Phase 2 / Phase 3TerminatedSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC402019-12-172026-05-22
Patient-caregiver Collaboration for Better Cardiovascular Care for Patients With Long-term Mental Disorders: Multicentre Qualitative and Feasibility Studies
Questionnaires (Phase 3), Focus groups (Phase 2), semi-structured interviews (Phase 1) - Long-term Mental Disorders
CompletedCentre Hospitalier Universitaire Dijon1272019-06-272026-02-05
Examining the Effects of Nasal High Flow Oxygen Therapy Compared to Non-invasive Ventilation in Health Volunteers
Phase 1 and 2, Phase 3 - Healthy Volunteers
Active not recruitingUnity Health Toronto202019-04-102026-09-24
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
Flu vaccination information in 3 phases - Human Influenza Vaccination in Healthcare Workers
Not applicableCompletedService de Médecine Préventive Hospitalière3792016-04-012018-09-28
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Rifaximin, Placebo - Rectal Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center692011-04-262024-05-14
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)
Acclimation, Dietary zinc depletion, Dietary zinc repletion - Zinc Deficiency
CompletedUniversity of Florida102009-10-012011-09-20
Healthy Living Partnership to Prevent Diabetes
Group-Based Lifestyle Intervention (Phases 1 and 2), Individual Education Program (All Phases), Self-Directed Maintenance (Phase 3) - Prediabetes, Obesity
Not applicableCompletedWake Forest University Health Sciences3012007-08-012020-02-05
Trials of Hypertension Prevention (TOHP)
diet, sodium-restricted (Phase III) diet, sodium-restricted, diet, reducing (Phase III) - Cardiovascular Diseases, Heart Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1986-09-012016-03-16

Conditions studied

Brain Injuries, Traumatic (2)  ·  Hemiplegia (2)  ·  Muscle Spasticity (2)  ·  Stroke (2)  ·  Anxiety Disorders (1)  ·  Blindness (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Palsy (1)  ·  Depressive Disorder (1)  ·  Heart Diseases (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Multiple Sclerosis (1)  ·  Mumps (1)  ·  Obesity (1)

Sponsors

Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (2)  ·  Sophie Román Richon (2)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  Drexel University (1)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Service de Médecine Préventive Hospitalière (1)  ·  Unity Health Toronto (1)  ·  University of Florida (1)  ·  University of Valencia (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (6)  ·  Spain (3)  ·  Hungary (2)  ·  Poland (2)  ·  Canada (1)  ·  China (1)  ·  France (1)

Top investigators

Joseph T Hull, PhD (2)  ·  Charles Hennekens (1)  ·  Laurent Brochard, MD (1)  ·  Mara Z Vitolins, DrPH MPH RDN (1)  ·  Philip Paty, MD (1)  ·  Qihan Li (1)  ·  Robert J Cousins, Ph.D. (1)

Results publications

PMID 21593290, PMID 22456662, PMID 23455686, PMID 23498294, PMID 23498303, PMID 25293442, PMID 25293586, PMID 27796775, PMID 28964720, PMID 31296648, PMID 31308621, PMID 31889999, PMID 32103890, PMID 33292400, PMID 42618283

NIH funding

R01DK031127 (1), R18DK069901 (1), U01HL037852 (1)